Mechanisms and Pathology of Monocrotaline Pulmonary Toxicity

References

• Cheeke P. R. Toxicity and metabolism of pyrrol-izidine alkaloids. J. Anim. Sci. 1988; 66: 2343
   PubMed Web of Science ®Google Scholar
• Mattocks A. R. Chemistry and Toxicology of Pyrrolidine Alkaloids. Academic Press, New York 1986
   Google Scholar
• Weir E. K. The United States experience with the acute and chronic treatment of primary pulmonary hypertension. Eur. Heart J. 1988, (Sept. Suppl. J), 33
   Google Scholar
• Kanemoto N., Constant J. Present status of primary pulmonary hypertension. Tokai J. Exp. Clin. Med. 1989; 14(4), 257
   PubMedGoogle Scholar
• Dinh Xuan A. T. D., Higenbottam T. W., Scott J. P., Wallwork J. Primary pulmonary hypertension: diagnosis, medical and surgical treatment. Respir. Med. 1990; 84: 189
   PubMedGoogle Scholar
• Trulock E. P., Cooper J. D., Kaiser L. R., Pasque M. K., Ettinger N. A., Dresler C. M. The Washington University-Barnes Hospital experience with lung transplantation. JAMA 1991; 266: 1943
   PubMedGoogle Scholar
• McCormack D. Endothelium-derived relaxing factors and the human pulmonary circulation. Lung 1990; 168(Suppl.)35
   PubMedGoogle Scholar
• Johns R. A. Endothelium-derived relaxing factor: basic review and clinical implications. J. Cardiothorac. Vase. Anesth. 1991; 5(1), 69
   PubMedGoogle Scholar
• Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 1991; 43: 109
   PubMed Web of Science ®Google Scholar
• Dusting G. J., MacDonald P. S. Prostacyclin and vascular function: implications for hypertension and atherosclerosis. Pharmacol. Ther. 1990; 48: 323
   PubMedGoogle Scholar
• Rubanyi G. M., Botelho L. H. Endothelins. FASEB J. 1991; 5(12), 2713
   PubMedGoogle Scholar
• Vender R. L., Clemmons D. R., Kwock L., Friedman M. Reduced oxygen tension induces pulmonary endothelium to release a pulmonary smooth muscle cell mitogen(s). Am. Rev. Respir. Dis. 1987; 135(3), 622
   PubMedGoogle Scholar
• Hannan R. L., Kourembanas S., Flanders K. C., Rogelj S. J., Roberts A. B., Faller D. V., Klagsbrun M. Endothelial cells synthesize basic fibroblast growth factor and transforming growth factor beta. Growth Factors 1988; 1(1), 7
   PubMedGoogle Scholar
• Rich S., Brundage B. H. Pulmonary hypertension: a cellular basis for understanding the pathophysiology and treatment. J. Am. Coll. Cardiol. 1989; 14(3), 545
   PubMedGoogle Scholar
• Hawkins J. W., Dunn M. I. Primary pulmonary hypertension in adults. Clin. Cardiol. 1990; 13(6), 382
   PubMedGoogle Scholar
• Witschi H., Last J. A. Pulmonary toxicology in. Handbook of Toxicology, T. J. Haley, W. O. Berndt. Hemisphere, Washington, DC 1987; 113
   Google Scholar
• Klinger J. R., Hill N. S. Right ventricular dysfunction in chronic obstructive pulmonary disease: evaluation and management. Chest 1991; 99(3), 715
   PubMedGoogle Scholar
• Palevsky H. I., Fishman A. P. Chronic cor pulmonale: etiology and management. JAMA 1990; 263(17), 2347
   PubMedGoogle Scholar
• Murphy M. L., Dinh H., Nicholson D. Chronic cor pulmonale. Disease-A-Month 1989; 35(10), 653
   PubMedGoogle Scholar
• Wagenvoort C. A., Wagenvoort N. Primary pulmonary hypertension: a pathological study of the lung vessels in 156 clinically diagnosed cases. Circulation 1970; 42: 1163
   Web of Science ®Google Scholar
• Mecham R. P., Whitehouse L. A., Wrenn D. S., Parks W. C., Griffin G. L., Senior R. M., Crouch E. C., Stenmark K. R., Voelkel N. F. Smooth muscle-mediated connective tissue remodeling in pulmonary hypertension. Science 1987; 237: 423
   PubMed Web of Science ®Google Scholar
• Snow R. L., Davies P., Pontoppidan H., Zapol W. M., Reid L. Pulmonary vascular remodeling in adult respiratory distress syndrome. Am. Rev. Respir. Dis. 1982; 126: 887
   PubMedGoogle Scholar
• Michel R. P., Smith T. T., Poulsen R. S. Distribution of fluid in bronchovascular bundles with permeability lung edema induced by alpha-naphthylthiourea in dogs a morphometric study. Lab. Invest. 1984; 51: 97
   PubMedGoogle Scholar
• Woods L. W., Wilson D. W., Schiedt M. J., Giri S. N. Structural and biochemical changes in lungs of 3-methylindole-treated rats. Am. J. Pathol., in press
   Google Scholar
• Meyrick B., Brigham K. L. Repeated Escherichia coli endotoxin-induced pulmonary inflammation causes chronic pulmonary hypertension in sheep. Lab. Invest. 1986; 55: 164
   PubMedGoogle Scholar
• Meyrick B., Brigham K. L. Acute effects of Escherichia coli endotoxin on the pulmonary microcirculation of anesthetized sheep - structure: function relationships. Lab. Invest. 1983; 48: 458
   PubMed Web of Science ®Google Scholar
• Ohar J. A., Waller K. S., DeMello D., Lagunoff D. Administration of chronic intravenous platelet-activating factor induces pulmonary arterial atrophy and hypertension in rabbits. Lab. Invest. 1991; 65: 451
   PubMedGoogle Scholar
• Todorovich-Hunter L., Johnson D. J., Ranger P., Keeley F. W., Rabinovitch M. Altered elastin and collagen synthesis associated with progressive pulmonary hypertension induced by mono-crotaline: a biochemical and ultrastructural study. Lab. Invest. 1988; 58: 184
   PubMed Web of Science ®Google Scholar
• Wilson D. W., Segall H. J., Pan L. C. W., Dunston S. K. Progressive inflammatory and structural changes in the pulmonary vasculature of monocrotaline-treated rats. Microvasc. Res. 1989; 38: 57
   PubMed Web of Science ®Google Scholar
• Meyrick B. O., Reid L. M. Crotalaria-induced pulmonary hypertension uptake of 3H-thymidine by the cells of the pulmonary circulation and alveolar walls. Am. J. Pathol. 1982; 106: 84
   PubMed Web of Science ®Google Scholar
• Kelly J. Cytokines of the lung. Am. Rev. Respir. Dis. 1990; 141: 765
   PubMed Web of Science ®Google Scholar
• Gillespie M. N., Rippetoe P. E., Haven C. A., Shiao R. -T., Orlinska U., Maley B. E., Olson J. W. Polyamines and epidermal growth factor in monocrotaline-induced pulmonary hypertension. Am. Rev. Respir. Dis. 1989; 140: 1463
   PubMed Web of Science ®Google Scholar
• Vender R. L., Clemmons D. R., Kwock L., Friedman M. Reduced oxygen tension induces pulmonary endothelium to release a pulmonary smooth muscle cell mitogen(s). Am. Rev. Respir. Dis. 1987; 135(3), 622
   PubMedGoogle Scholar
• Lalich J. J., Merkow L. Pulmonary arteritis produced in rats by feeding. Crotalaria spectabilis, Lab. Invest. 1961; 10: 744
   PubMed Web of Science ®Google Scholar
• Wilson D. W., Segall H. J. Changes in type II cell populations in monocrotaline pneumotoxicity. Am. J. Pathol. 1990; 136: 1293
   PubMedGoogle Scholar
• Reindel J. F., Chang C. C., Madhukar B. V., Roth R. A. Monocrotaline pyrrole induces antiproliferative and delayed cytotoxic responses in cultured cells. Lung Pathophysiol. 1988; A1181: 5142
   Google Scholar
• Smith L. W., Culvenor C. C. J. Plant sources of hepatotoxic pyrrolizidine alkaloids. J. Nat. Products 1981; 44: 129
   PubMed Web of Science ®Google Scholar
• Bull L. B., Culvenor C. C. J., Dick A. T. The pyrrolizidine alkaloids, in. Frontiers of Biology. North-Holland, Amsterdam 1968
   Google Scholar
• Mohabbat O., Younos M. S., Merzad A. A., Srivastava R. N., Sediq G. G., Aram G. N. An outbreak of hepatic veno-occlusive disease in northwestern Afghanistan. Lancet 1976; 269
   Google Scholar
• Tandon B. M., Tandon R. K., Tandon H. D., Narndranathan M., Joshi Y. K. An epidemic of veno-occlusive disease of liver in central India. Lancet 1976; 2: 271
   PubMed Web of Science ®Google Scholar
• Schoental R. Health hazards of pyrrolizidine alkaloids: a short review. Toxicol. Lett. 1982; 10: 323
   PubMed Web of Science ®Google Scholar
• Bras G., Jelliffee D. B., Stuart K. L. Veno-occlusive disease of liver with non-portal type of cirrhosis occurring in Jamaica. Arch. Pathol. 1954; 57: 285
   PubMedGoogle Scholar
• McLean E. K. The toxic actions of pyrrolizidine (Senecio) alkaloids. Pharmacol. Rev. 1970; 22: 429
   PubMedGoogle Scholar
• Deinzer M. L., Thomson P. A., Burgett D. M., Isaacson D. L. Pyrrolizidine alkaloids: their occurrence in honey from tansy ragwort (Senecio jacobaea L.). Science 1977; 195: 497
   PubMed Web of Science ®Google Scholar
• Culvenor C. C. J., Edgar J. A., Smith L. W. Pyrrolizidine alkaloids in honey from Echium plantagineum L. J. Agric. Food Chem. 1981; 29: 958
   PubMed Web of Science ®Google Scholar
• Stillman A. E., Huxtable R., Consroe P., Kohnen P., Smith S. Hepatic veno-occlusive disease due to pyrrolizidine (senecio) poisoning in Arizona. Gastroenterology 1977; 73: 349
   PubMed Web of Science ®Google Scholar
• Huxtable R., Stillman A., Ciaramitaro D. Characterization of alkaloids involved in human senecio (pyrrolizidine) poisoning. Proc. West. Pharmacol. Soc. 1977; 20: 455
   PubMedGoogle Scholar
• Huxtable R. J. Herbal teas and toxins: novel aspects of pyrrolizidine poisoning in the United States. Perspect. Biol. Med. 1980; 24: 1
   PubMed Web of Science ®Google Scholar
• Shulman H. M., Luk K., Deeg H. J., Shuman W. B., Storb R. Induction of hepatic veno-occlusive disease in dogs. Am. J. Pathol. 1987; 126: 114
   PubMed Web of Science ®Google Scholar
• Allen J. R., Chesney C. F. Effect of age on development of cor pulmonale in nonhuman primates following pyrrolizidine alkaloid intoxication. Exp. Mol. Pathol. 1972; 17: 220
   PubMedGoogle Scholar
• Miller W. C., Rice D. L., Kreusel R. G., Bedrossian W. M. Monocrotaline model of non-cardiogenic pulmonary edema in dogs. J. Appl. Physiol. 1978; 45: 962
   PubMedGoogle Scholar
• Wagenvoort W. C. A., Wagenvoort N., Dijk H. J. Effect of fulvine on pulmonary arteries and veins of the rat. Thorax 1974; 29: 522
   PubMed Web of Science ®Google Scholar
• Ghodsi F., Will J. A. Changes in pulmonary structure and function induced by monocrotaline intoxication. Am. J. Physiol. 1981; 240: H149
   PubMed Web of Science ®Google Scholar
• Barnes J. M., Magee P. N., Schoental R. Lesions in the lungs and livers of rats poisoned with the pyrrolidine alkaloid fulvine and its N-oxide. J. Pathol. Bacteriol. 1964; 88: 521
   PubMedGoogle Scholar
• Molteni A., Ward W. F., Ts'ao C., Solliday N. H. Monocrotaline-induced cardiopulmonary injury in rats; modification by the nonthiol ACE inhibitors CGS13945 and CGS16617. Arch. Int. Pharmacodyn. 1988; 291: 21
   PubMedGoogle Scholar
• Mattocks A. R. Acute hepatotoxicity and pyrrolic metabolites in rats dosed with pyrrolidine alkaloids. Chem.-Biol. Interact. 1972; 5: 227
   PubMed Web of Science ®Google Scholar
• Hooper P. T., Scanlan W. A. Crotalaria retusa poisoning of pigs and poultry. Aust. Vet. J. 1977; 53: 109
   PubMedGoogle Scholar
• Peckham J. C., Sangster L. T., Jones O. H. Crotalaria spectabilis poisoning in swine. JAVMA 1974; 165: 633
   PubMedGoogle Scholar
• Allen J. R., Carstens L. A., Olson B. E. Veno-occlusive disease in Macaca speciosa monkeys. Am. J. Pathol. 1967; 50: 653
   PubMedGoogle Scholar
• Turner J. H., Lalich J. J. Experimental cor pulmonale in the rat. Arch. Pathol. 1965; 79: 409
   PubMedGoogle Scholar
• Merkow L., Kleinerman J. An electron microscopic study of pulmonary vasculitis induced by monocrotaline. Lab. Invest. 1966; 15: 547
   PubMed Web of Science ®Google Scholar
• Kay J. M., Keane P. M., Suyama K. L. Pulmonary hypertension induced in rats by monocrotaline and chronic hypoxia is reduced byp-chlo-rophenylalanine. Respiration 1985; 47: 48
   PubMedGoogle Scholar
• Koletsky A., Oyasu R., Reddy J. K. Mutagenicity of the pyrrolidine (Senecio) alkaloid lasiocarpine in the Salmonella/microsome test. Lab. Invest. 1978; 38: 352
   Google Scholar
• Kay J. M., Heath D. Observations on the pulmonary arteries and heart weight of rats fed onCrotalaria spectabilis seeds. J. Pathol. Bacteriol. 1966; 92: 385
   PubMedGoogle Scholar
• Sugita T., Hyers T. M., Dauber I. M., Wagner W. W., McMurtry I. F., Reeves J. T. Lung vessel leak precedes right ventricular hypertrophy in monocrotaline-treated rats. J. Appl. Physiol. 1983; 54: 371
   PubMed Web of Science ®Google Scholar
• Hayashi Y. Excretion and alteration of monocrotaline in rats after a subcutaneous injection. FASEB J. 1966; 25: 688
   Google Scholar
• Hilliker K. S., Bell T. G., Roth R. A. Pneumotoxicity and thrombocytopenia after single injection of monocrotaline. Am. J. Physiol. 1982; 242: H573
   PubMed Web of Science ®Google Scholar
• Hsu C. I., Allen J. R., Shumaker R. C. Tissue distribution of tritium-labeled dehydroretronecine. Chem.-Biol. Interact. 1974; 8: 163
   PubMedGoogle Scholar
• Plestina R., Stoner H. B. Pulmonary oedema in rats given monocrotaline pyrrole. J. Pathol. 1972; 106: 235
   PubMed Web of Science ®Google Scholar
• Valdivia E., Sonnad J., Hayashi Y., Lalich J. J. Experimental interstitial pulmonary edema. Angiology 1967; 18: 378
   PubMed Web of Science ®Google Scholar
• Petry T. W., Bowden G. T., Huxtable R. J., Sipes I. G. Characterization of hepatic DNA damage induced in rats by the pyrrolizidine alkaloid monocrotaline. Cancer Res. 1984; 44: 1505
   PubMed Web of Science ®Google Scholar
• Culvenor C. C. J., Downing D. T., Edgar J. A., Jago M. V. Pyrrolizidine alkaloids as alkylating and antimitotic agents. Ann. N. Y. Acad. Sci. 1969; 163: 837
   Web of Science ®Google Scholar
• Hincks J. R., Kim H. -Y., Segall H. J., Molyneux R. J., Stermitz F. R., Coulombe R. A. DNA cross-linking in mammalian cells by pyrrolizidine alkaloids: structure activity relationships. Toxicol. Appl. Pharmacol. 1991; 111: 90
   PubMed Web of Science ®Google Scholar
• Mattocks A. R., White I. N. H. Toxic effects and pyrrolic metabolites in the liver of young rats given the pyrrolizidine alkaloid retrorsine. Chem.-Biol. Interact. 1973; 6: 297
   PubMedGoogle Scholar
• Wilson D. W., Hacker A. H., Segall H. J. Cell proliferation in the lungs of monocrotaline-treated rats in. Proc. 3rd Int. Symp. Poisonous Plants, L. F. James, R. F. Keeler, E. M. Bailey, P. R. Cheeke, M. P. Hegarty. Iowa State University Press, Ames 1992; 225
   Google Scholar
• Woods L. W., Wilson D. W. Monocrotaline inhibition of 3-methylindole-induced type II cell hyperplasia. Proc. Am. Coll. Vet. Pathol. 1989; 30
   Google Scholar
• Ganey P. E., Fink G. D., Roth R. A. The effect of dietary restriction and altered sodium intake on the cardiopulmonary toxicity of monocrotaline pyrrole. Toxicol. Appl. Pharmacol. 1985; 78: 55
   PubMed Web of Science ®Google Scholar
• Hayashi Y., Kato M., Otusuka H. Inhibitory effects of diet-reduction on monocrotaline intoxication in rats. Toxicol. Lett. 1979; 3: 151
   Google Scholar
• Todd L., Mullen M., Olley P. M., Rabinovitch M. Pulmonary toxicity of monocrotaline differs at critical periods of lung development. Pediatr. Res. 1985; 19: 731
   PubMed Web of Science ®Google Scholar
• Olson J. W., Atkinson J. E., Hacker A. D., Altiere R. J., Gillespie M. N. Suppression of polyamine biosynthesis prevents monocrotaline-induced pulmonary edema and arterial medial thickening. Toxicol. Appl. Pharmacol. 1985; 81: 91
   PubMed Web of Science ®Google Scholar
• Lafranconi W. M., Huxtable R. J. Hepatic metabolism and pulmonary toxicity of monocrotaline using isolated perfused liver and lung. Biochem. Pharmacol. 1984; 33: 2479
   PubMed Web of Science ®Google Scholar
• Mattocks A. R. Toxicity and metabolism of Senecio alkaloids, in. Phytochemical Ecology, J. B. Harborne. Academic Press, New York 1972; 179
   Google Scholar
• Allen J. R., Chesney C. F., Frazee W. J. Modifications of pyrrolizidine alkaloid intoxication resulting from altered hepatic microsomal enzymes. Toxicol. Appl. Pharmacol. 1972; 23: 470
   PubMed Web of Science ®Google Scholar
• Mattocks A. R. Oxidation of retronecine and synthanecine A to aldehydes. J. Chem. Res., S. 1977; 40
   Google Scholar
• Pan L. C., Lame M. W., Morin D., Wilson D. W., Segall H. J. Red blood cells augment transport of reactive metabolites of monocrotaline from liver to lung in isolated and tandem liver and lung preparations. Toxicol. Appl. Pharmacol. 1991; 110: 336
   PubMedGoogle Scholar
• Estep J. E., Lamé M. W., Segall H. J. Excretion and blood radioactivity levels following 14C-senecionine administration in the rat. Toxicology 1990; 64: 179
   PubMed Web of Science ®Google Scholar
• Estep J. E., Lame M. W., Morin D., Jones A. D., Wilson D. W., Segall H. J. 14C-monocrotaline kinetics and metabolism in the rat. Drug Metab. Dispos. 1991; 19: 135
   PubMed Web of Science ®Google Scholar
• Mattocks A. R., White I. N. H. The conversion of pyrrolidine alkaloids to N-oxides and to dihydropyrrolizine derivatives by rat-liver microsomes in vitro. Chem.-Biol. Interact. 1971; 3: 383
   PubMed Web of Science ®Google Scholar
• Mattocks A. R. Toxicity of pyrrolizidine-alkaloids. Nature 1968; 211: 123
   Google Scholar
• Hilliker K. S., Garcia C. M., Roth R. A. Effects of monocrotaline pyrrole on 5-hydroxytryptamine and paraquat uptake by lung slices. Res. Commun. Chem. Pathol. Pharmacol. 1983; 40: 179
   PubMedGoogle Scholar
• Ganey P. E., Sprugel K. H., White S. M., Wagner J. G., Roth R. A. Pulmonary hypertension due to monocrotaline pyrrole is reduced by moderate thrombocytopenia. Am. J. Physiol. 1988; 255: H1165
   Google Scholar
• Ganey P. E., Sprugel K. H., Hadley K. B., Roth R. A. Monocrotaline pyrrole-induced cardiopulmonary toxicity is not altered by metergoline or ketanserin. J. Pharmacol. Exp. Ther. 1986; 231: 226
   Google Scholar
• Hilliker K. S., Roth R. A. Increased vascular responsiveness in lungs of rats with pulmonary hypertension induced by monocrotaline pyrrole. Am. Rev. Respir. Dis. 1985; 131: 46
   PubMedGoogle Scholar
• Hilliker K. S., Bell T. G., Lorimer D., Roth R. A. Effects of thrombocytopenia on monocrotaline pyrrole-induced pulmonary hypertension. Am. J. Physiol. 1984; 246: H747
   Google Scholar
• Bruner L. H., Hilliker K. S., Roth R. A. Cyclosporin A (CyA) and dexamethasone (DX) protect rats from the cardiopulmonary effects of monocrotaline pyrrole. Physiologist 1983; 26: A-57
   Google Scholar
• Hilliker K. S., Roth R. A. Injury to the isolated, perfused lung by exposure in vitro to monocrotaline pyrrole. Exp. Lung Res. 1984; 8: 201
   Google Scholar
• Bruner L. H., Johnson K. J., Till G. O., Roth R. A. Complement is not involved in monocrotaline pyrrole-induced pulmonary injury. Am. J. Physiol. 1988; 254: H258
   Google Scholar
• White S. M., Roth R. A. Pulmonary platelet sequestration is increased following monocrotaline pyrrole treatment of rats. Toxicol. Appl. Pharmacol. 1988; 96: 465
   PubMedGoogle Scholar
• Bruner L. H., Johnson K., Carpenter L. J., Roth R. A. Lack of effects of deferoxamine, dimethyl sulfoxide, and catalase on monocrotaline pyrrole pulmonary injury. J. Toxicol. Environ. Health 1987; 21: 205
   PubMed Web of Science ®Google Scholar
• White S. M., Wagner J. G., Roth R. A. Effects of altered platelet number on pulmonary hypertension and platelet sequestration in monocrotaline pyrrole-treated rats. Toxicol. Appl. Pharmacol. 1989; 99: 302
   PubMedGoogle Scholar
• Ganey P. E., Roth R. A. Thromboxane does not mediate pulmonary vascular response to monocrotaline pyrrole. Am. J. Physiol. 1987; 252: H743
   Google Scholar
• Bruner L. H., Carpenter L. J., Hamlow P., Roth R. A. Effect of a mixed function oxidase inducer and inhibitor on monocrotaline pyrrole pneu-motoxicity. Toxicol. Appl. Pharmacol. 1986; 85: 416
   PubMed Web of Science ®Google Scholar
• Estep J. E., Lame M. W., Jones A. D., Segall H. J. N-Acetylcysteine-conjugated pyrrole identified in rat urine following administration of two pyrrolizidine alkaloids, monocrotaline and senecion-ine. Toxicol. Lett. 1990; 54: 61
   PubMed Web of Science ®Google Scholar
• Lamé M. W., Jones A. D., Morin D., Segall H. J. Metabolism of [14C]monocrotaline by isolated perfused rat liver. Drug Metab. Dispos. 1991; 19: 516
   PubMed Web of Science ®Google Scholar
• Bruner L. H., Hilliker K. S., Roth R. A. Pulmonary hypertension and ECG changes from monocrotaline pyrrole in the rat. Am. J. Physiol. 1983; 245: H300
   PubMed Web of Science ®Google Scholar
• Estep J. E., Lame M. W., Morin D., Segall H. J., Wilson D. W. 14C-Monocrotaline tissue distribution, covalent binding, and kinetics in the rat, in. Proc. 3rd Int. Symp. on Poisonous Plants, L. F. Lames, R. F. Keeler, E. M. Bailey, P. R. Cheeke, M. P. Hegarty. Iowa State University Press, Ames 1992; 584
   Google Scholar
• Pan L. C., Wilson D. W., Segall H. J., Lame M. W., Morin D. Red blood cells from monocrotaline treated rats decrease serotonin removal in isolated perfused lungs. Toxicologist 1990; 10: 101
   Google Scholar
• Awasthi Y. C., Garg H. S., Dao D. D., Partridge C. A., Srivastava S. K. Enzymatic conjugation of erythrocyte glutathione with l-chloro-2,4-dinitrobenzene: the fate of glutathione conjugate in erythrocytes and the effect of glutathione depletion on hemoglobin. Blood 1981; 58: 733
   PubMed Web of Science ®Google Scholar
• Awasthi Y. C., Misra G., Rassin D. K., Srivastava S. K. Detoxification of xenobiotics by glutathione S-transferases in erythrocytes: the transport of the conjugate of glutathione and 1-chloro-2,4-dinitrobenzene. Br. J. Haematol. 1983; 55: 419
   PubMed Web of Science ®Google Scholar
• LaBelle E. F., Singh S. V., Srivastava S. K., Awasthi Y. G. Dinitrophenyl glutathione efflux from human erythrocytes is primary active ATP-dependent transport. Biochem. J. 1986; 238: 443
   PubMed Web of Science ®Google Scholar
• Awasthi Y. C., Singh S. V., Ahmad H., Wronski L. W., Srivastava S. K., LaBelle E. F. ATP dependent primary active transport of xenobiotic-glu-tathione conjugates by human erythrocyte membrane. Mol. Cell. Biochem. 1989; 91: 131
   PubMedGoogle Scholar
• Ganey P. E., Fink G. D., Roth R. A. The effect of dietary restriction and altered sodium intake on the cardiopulmonary toxicity of monocrotaline pyrrole. Toxicol. Appl. Pharmacol. 1985; 78: 55
   PubMed Web of Science ®Google Scholar
• Hilliker K. S., Roth R. A. Alteration of monocrotaline pyrrole-induced cardiopulmonary effects in rats by hydralazine, dexamethasone or sulphin-pyrazone. Br. J. Pharmacol. 1984; 82: 375
   PubMedGoogle Scholar
• Langleben D., Reid L. M. Effect of methylprednisolone on monocrotaline-induced pulmonary vascular disease and right ventricular hypertrophy. Lab. Invest. 1985; 52: 298
   PubMedGoogle Scholar
• Gillespie M. N., Goldblum S. E., Cohen D. A., McClain C. J. Interleukin 1 bioreactivity in the lungs of rats with monocrotaline induced hypertension. Proc. Soc. Exp. Biol. Med. 1988; 187: 26
   PubMedGoogle Scholar
• Bruner L. H., Bull R. W., Roth R. A. The effect of immunosuppressants and adoptive transfer in monocrotaline pyrrole pneumotoxicity. Toxicol. Appl. Pharmacol., 91: 1, 1987
   PubMedGoogle Scholar
• Ganey P. E., Hilliker-Sprugel K., Hadley K. B., Roth R. A. Monocrotaline pyrrole-induced cardiopulmonary toxicity is not altered by metergo-line or ketanserin. J. Pharmacol. Exp. Ther. 1986; 237: 226
   PubMedGoogle Scholar
• Beviiacqua M. P., Stengelin S., Gimbrone M. A., Jr., Seed B. Endothelial leukocyte adhesion molecule. I. An inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989; 243: 1160
   PubMedGoogle Scholar
• Meyrick B., Gamble W., Reid L. Development of crotalaria pulmonary hypertension: hemodynamic and structural study. Am. J. Physiol. 1980; 239: H692
   PubMed Web of Science ®Google Scholar
• Stenmark K., Crouch E. C., Parks W. C. Regional heterogeneity of elastin and collagen gene expression in intralobar arteries in response to hypoxic pulmonary hypertension and demonstrated by in situ hybridization. Am. J. Pathol. 1989; 135: 1073
   PubMedGoogle Scholar
• Hayashi Y., Kokubo T., Takahashi M., Furukawa F., Otsuka H., Hashimoto K. Correlative morphological and biochemical studies monocrotaline-induced pulmonary alterations in rats. Toxicol. Lett. 1984; 21: 65
   PubMedGoogle Scholar
• Shale D. J., Wiseman M. S., Cookson W. O. C. M. Effect of monocrotaline ingestion on the distribution of protein and angiotensin converting enzyme activity in the rat lung. Thorax 1986; 41: 914
   PubMed Web of Science ®Google Scholar
• Lafranconi W. M., Huxtable R. J. Changes in angiotensin-converting enzyme activity in lungs damaged by the pyrrolizidine alkaloid monocrotaline. Thorax 1983; 38: 307
   PubMedGoogle Scholar
• Molteni A., Ward W. E., Ts'ao C., Port C. D., Solloday N. H. Monocrotaline-induced pulmonary endothelial dysfunction in rats. Proc. Soc. Exp. Biol. Med. 1984; 176: 88
   PubMedGoogle Scholar